SynthesisInternational journal of molecular sciences2022

The Utilization of Bevacizumab in Patients with Advanced Ovarian Cancer: A Systematic Review of the Mechanisms and Effects.

Chih-Lin Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.